Visfatin: A potential therapeutic target for rheumatoid arthritis

Journal of International Medical Research

Volumn 37, Issue 6, 2009, Pages 1655-1661

  Bao, J P ^a   Chen, W P ^a   Wu, Li Dong ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Rheumatoid arthritis; Therapeutic target; Visfatin

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; CYTOKINE; N [4 (1 BENZOYL 4 PIPERIDINYL)BUTYL] 3 (3 PYRIDINYL)ACRYLAMIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTHRITIS; CATALYSIS; CELL TYPE; CYTOKINE PRODUCTION; DNA LIBRARY; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; PHYSIOLOGY; REVIEW; RHEUMATOID ARTHRITIS;

EID: 74949141847     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700601     Document Type: Review

References (34)

1. Lundy SK, Sarkar S, Tesmer LA, et al: Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res Ther 2007; 9: 202.
2. Feldmann M, Brennan FM, Maini RN: Rheumatoid arthritis. Cell 1996; 85: 307-310.
3. Brentano F, Kyburz D, Schorr O, et al: The role of Toll-like receptor signalling in the pathogenesis of arthritis. Cell Immunol 2005; 233: 90-96.
4. Rho YH, Solus J, Sokka T, et al: Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum 2009; 60: 1906-1914.
5. Brentano F, Schorr O, Ospelt C, et al: Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrixdegrading activities. Arthritis Rheum 2007; 56: 2829-2839.
6. Nowell MA, Richards PJ, Fielding CA, et al: Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 transsignaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 2006; 54: 2084-2095.
7. Otero M, Lago R, Gomez R, et al: Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 2006; 65: 1198-1201.
8. Gabay O, Hall DJ, Berenbaum F, et al: Osteoarthritis and obesity: experimental models. Joint Bone Spine 2008; 75: 675-679.
9. Moschen AR, Kaser A, Enrich B, et al: Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 2007; 178: 1748-1758.
10. Busso N, Karababa M, Nobile M, et al: Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. PloS One 2008; 3: e2267.
11. Samal B, Sun Y, Stearns G, et al: Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994; 14: 1431-1437.
12. Rongvaux A, Shea RJ, Mulks MH, et al: Pre-Bcell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 2002; 32: 3225 - 3234.
13. Fukuhara A, Matsuda M, Nishizawa M, et al: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426-430.
14. Kim MK, Lee JH, Kim H, et al: Crystal structure of visfatin/pre-B cell colony-enhancing factor 1/nicotinamide phosphoribosyltransferase, free and in complex with the anti-cancer agent FK-866. J Mol Biol 2006; 362: 66-77.
15. Jia SH, Li Y, Parodo J, et al: Pre-B cell colonyenhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004; 113: 1318-1327.
16. Ognjanovic S, Bryant-Greenwood GD: Pre-Bcell colony-enhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol 2002; 187: 1051-1058.
17. Curat CA, Wegner V, Sengenes C, et al: Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006; 49: 744-747.
18. Arner P: Visfatin-a true or false trail to type 2 diabetes mellitus. J Clin Endocrinol Metab 2006; 91: 28-30.
19. Hug C, Lodish HF: Medicine. Visfatin: a new adipokine. Science 2005; 307: 366-367.
20. van der Veer E, Nong Z, O'Neil C, et al: Pre-Bcell colony-enhancing factor regulates NAD+-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation. Circ Res 2005; 97: 25-34.
21. Kitani T, Okuno S, Fujisawa H: Growth phasedependent changes in the subcellular localization of pre-B-cell colony-enhancing factor. FEBS Lett 2003; 544: 74-78.
22. Ognjanovic S, Bao S, Yamamoto SY, et al: Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol 2001; 26: 107-117.
23. Ye SQ, Zhang LQ, Adyshev D, et al: Pre-B-cellcolony-enhancing factor is critically involved in thrombin-induced lung endothelial cell barrier dysregulation. Microvasc Res 2005; 70: 142-151.
24. Iqbal J, Zaidi M: TNF regulates cellular NAD+ metabolism in primary macrophages. Biochem Biophys Res Commun 2006; 342: 1312-1318.
25. Nemeth E, Tashima LS, Yu Z, et al: Fetal membrane distention: I. Differentially expressed genes regulated by acute distention in amniotic epithelial (WISH) cells. Am J Obstet Gynecol 2000; 182: 50-59.
26. Matsui H, Tsutsumi A, Sugihara M, et al: Visfatin (pre-B cell colony-enhancing factor) gene expression in patients with rheumatoid arthritis. Ann Rheum Dis 2008; 67: 571-572.
27. Dvir-Ginzberg M, Gagarina V, Lee EJ, et al: Regulation of cartilage-specific gene expression in human chondrocytes by SirT1 and nicotinamide phosphoribosyltransferase. J Biol Chem 2008; 283: 36300-36310.
28. Gosset M, Berenbaum F, Salvat C, et al: Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis. Arthritis Rheum 2008; 58: 1399-1409.
29. Dahl TB, Yndestad A, Skjelland M, et al: Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 2007; 115: 972-980.
30. Berndt J, Kloting N, Kralisch S, et al: Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005; 54: 2911-2916.
31. Chen MP, Chung FM, Chang DM, et al: Elevated plasma level of visfatin/pre-B cell colonyenhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006; 91: 295-299.
32. Haider DG, Pleiner J, Francesconi M, et al: Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes. J Clin Endocrinol Metab 2006; 91: 4702-4704.
33. Dogru T, Sonmez A, Tasci I, et al: Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract 2007; 76: 24-29.
34. Xie H, Tang SY, Luo XH, et al: Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue Int 2007; 80: 201-210.